e-learning
resources
Stockholm 2007
Monday 17.09.2007
Rare tumours, risk factors and epidemiology in thoracic oncology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Trends of the proportion of small-cell lung cancer (SCLC) over the last 20 year: a university medical center experience
I. L. Santoro, R. A. Ybanez, S. Jamnik, C. Uehara, A. L. G. Fernandes (São Paulo, SP, Brazil)
Source:
Annual Congress 2007 - Rare tumours, risk factors and epidemiology in thoracic oncology
Session:
Rare tumours, risk factors and epidemiology in thoracic oncology
Session type:
Thematic Poster Session
Number:
2509
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. L. Santoro, R. A. Ybanez, S. Jamnik, C. Uehara, A. L. G. Fernandes (São Paulo, SP, Brazil). Trends of the proportion of small-cell lung cancer (SCLC) over the last 20 year: a university medical center experience. Eur Respir J 2007; 30: Suppl. 51, 2509
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
To code or not to code chronic pulmonary aspergillosis associated malnutrition in PMSI database: that is the problem…
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Related content which might interest you:
Comparison of non-small cell lung cancer (NSCLC) management and survival in 1995 and 2005 at a London teaching hospital
Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology
Year: 2008
Survival with in-operable non-small cell lung cancer in U.K district general hospital: Is chemotherapy better than active supportive care?
Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients
Year: 2010
Use of erlotinib in management of advanced non-small cell lung cancer (NSCLC): The Czech Republic experience with the treatment of a non-selected population of 1735 patients (pts)
Source: Annual Congress 2011 - Treatment of lung cancer
Year: 2011
Locally advanced and metastatic lung cancer management delay: Tunisian department experience
Source: International Congress 2016 – Quality management and quality of life in lung cancer
Year: 2016
Trends in drug costs and overall survival in patients diagnosed with metastatic non-small cell lung cancer (NSCLC)
Source: International Congress 2019 – How to guide patients to reach a balance between costs and personal needs: quality indicators of effectiveness
Year: 2019
Major changes in men with non-small-cell lung cancer (NSCLC) in 10 years: The KBP-2000-CPHG and KBP-2010-CPHG cohorts
Source: Annual Congress 2013 –Epidemiology, screening and diagnosis of lung cancer
Year: 2013
Direct to surgery treatment of suspected lung cancer – results from a UK lung cancer multidisciplinary team (MDT)
Source: Virtual Congress 2021 – Innovation in thoracic surgery
Year: 2021
Osimertinib as a second-line treatment for EGFR-mutated non-small cell lung cancer: the experience of a Pulmonology department
Source: Virtual Congress 2020 – Real-world data and registries of thoracic oncology
Year: 2020
Clinical outcome of Pembrolizumab (PEMB) monotherapy in patients (pts) with advanced non-small cell lung cancer (NSCLC) – Reports from routine clinical care.
Source: International Congress 2019 – Treatment of lung cancer
Year: 2019
Single institution experience in advanced non-small cell lung cancer (NSCLC) patients (pts) with erlotinib (Tarceva®) within a large extended access programme* (EAP)
Source: Eur Respir J 2006; 28: Suppl. 50, 772s
Year: 2006
KRAS mutations in non-small cell lung cancer (NSCLC) – Experiences by routine molecular testing in a German lung cancer centre
Source: Annual Congress 2011 - Epidemiology of lung cancer and screening
Year: 2011
Patient and doctor delays in the diagnosis and treatment of non-small cell lung cancer in Turkey
Source: Annual Congress 2013 –Quality management in thoracic oncology
Year: 2013
The role of palliative radiotherapy in locally advanced non small cell lung cancer
Source: Annual Congress 2007 - Therapy of lung cancer
Year: 2007
Integration of palliative care from the very beginning to the very end in a patient with metastasised non-small cell lung cancer
Source: International Congress 2018 – CC3 Lung cancer: personalised treatment and palliative care
Year: 2018
Survival outcomes in advance non-small cell lung cancer – A developing country scenario
Source: Annual Congress 2011 - Quality management for lung cancer patients
Year: 2011
The proportion of lung cancer patients attending UK lung cancer clinics who would have been eligible for low-dose CT screening
Source: Eur Respir J, 54 (2) 1802221; 10.1183/13993003.02221-2018
Year: 2019
A prospective study of survival after surgery for early stage non-small cell lung cancer in patients with COPD
Source: International Congress 2015 – Risk assessment and prevention of complications in thoracic surgery
Year: 2015
EGF-receptor mutation in non-small cell lung cancer – Experiences by routine molecular testing in a German lung cancer centre
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010
Advanced non-small cell lung cancer (NSCLC): observation of chemotherapy in 5 European countries
Source: Annual Congress 2007 - Therapy of lung cancer
Year: 2007
Expressed wishes and incidence of euthanasia in advanced lung cancer patients},
Source: Eur Respir J 2012; 40: 949-956
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept